Transport Mechanism-Based Drug Molecular Design: Novel Camptothecin Analogues to Circumvent ABCG2-associated Drug Resistance of Human Tumor Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|3|313-325

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.3, 2006-01, pp. : 313-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Speed Screening and Quantitative SAR Analysis of Human ABC Transporter ABCG2 for Molecular Modeling of Anticancer Drugs to Circumvent Multidrug Resistance

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-10 ,pp. : 1009-1018

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets for Design of Novel Inhibitors to Circumvent Aminoglycoside Resistance

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-01 ,pp. : 353-361

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 2, 2009-02 ,pp. : 130-147

Bentham Science Publishers

Access to resources Recommend Favorite

Human Multidrug Transporter ABCG2, a Target for Sensitizing Drug Resistance in Cancer Chemotherapy

By  

Current Medicinal Chemistry, Vol. 14, Iss. 6, 2007-03 ,pp. : 689-701

Bentham Science Publishers

Access to resources Recommend Favorite

Camptothecin Resistance in Cancer: Insights into the Molecular Mechanisms of a DNA-Damaging Drug

By  

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1541-1565

Bentham Science Publishers

Access to resources Recommend Favorite